V-Nano

V-Nano is a South Korean biotechnology company specializing in the development of advanced vaccine delivery systems and adjuvants using its proprietary virus-mimicking nanoparticle (V-Nano) technology. The company's platform is designed to enhance the efficacy of vaccines and cancer immunotherapies by mimicking the structural and functional characteristics of viruses to trigger robust immune responses. V-Nano focuses on addressing global health challenges, including infectious diseases like COVID-19 and influenza, as well as various types of cancer. By leveraging its expertise in nanotechnology and immunology, the company aims to provide safer and more effective prophylactic and therapeutic solutions. Their research emphasizes the use of lipid-based and polymer-based nanoparticles to deliver antigens and immunostimulants efficiently.